Cingulate Gears Up for Commercialization as FDA Nods to Marketing Approval Application for CTx-1301
Aug 14, 2024
Approval Equities
Arcutis Biotherapeutics to Discuss ZORYVE® (Roflumilast Cream 0.15%) FDA Approval in Upcoming KOL Event
Jul 23, 2024
Biogen Announces European Approval for Tocilizumab Biosimilar, TOFIDENCE™
Jun 25, 2024
Ipsen Achieves FDA Accelerated Approval for Iqirvo® as Innovative PPAR Treatment for Primary Biliary Cholangitis
Jun 11, 2024
Cidara Therapeutics Celebrates European Commission Approval for Rezzayo as Stocks Soar
Dec 27, 2023